Editorial companion

What stands out

Stephen Yiu warns that the current Artificial Intelligence (AI) boom, driven by investor enthusiasm for models and chips, could disappoint if revenue and profit growth fail to follow the hype. He highlights a clear rotation idea: buying gold miners as an insurance trade against overheating markets, and lays out specific diversification candidates, healthcare drugs like GLP-1 (glucagon-like peptide-1 therapies), quantum computing, and geopolitical risks that could reshape sector leadership. The conversation pairs a skeptical view of an earnings bubble with concrete reallocation ideas.